Tuesday, November 24, 2009, 10:29pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

Cord Blood America Inc. (CBAI.OB)

 At 15:57 EST: 0.0048 USD  Down 0.0002 (4.00%)  
MORE ON CBAI.OB
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
CORD BLOOD AMERICA (OTC BB:CBAI.OB) Delayed quote dataEdit
Last Trade: 0.0048 USD
Trade Time: 3:57PM EST
Change: Down 0.0002 (4.00%)
Prev Close: 0.005
Open: 0.005
Bid: 0.0048 x 5000
Ask: 0.0049 x 5000
1y Target Est: N/A
Day's Range: 0.0048 - 0.005
52wk Range: 0.01 - 0.07
Volume: 29,836,169
Avg Vol (3m): 514,800
Market Cap: 21.93M
P/E (ttm): N/A
EPS (ttm): -0.005
Div & Yield: N/A (N/A%)
Cord Blood America Inc. (CBAI.OB)
1d  5d  3m  6m  1y  2y  5y 
 Add CBAI.OB to Portfolio   Download Data

HEADLINES
• Cord Blood America CEO Matthew Schissler Interviewed on Company's Progress
PRNewswire (Mon 8:01am)
• CORD BLOOD AMERICA, INC. Financials
EDGAR Online Financials (Thu, Nov 19)
• Cord Blood America Announces Debt Down; Gross Margins Up: Balance Sheet Significantly Improved
PRNewswire (Mon, Nov 16)
• CORD BLOOD AMERICA, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 13)
• Cord Blood America Updates Advantages of Las Vegas Laboratory in Analyst Interview; Explains Recent S1 Filing
PRNewswire (Fri, Nov 6)
• Cord Blood America's New Las Vegas Laboratory Director in Analyst Interview
PRNewswire (Fri, Oct 30)
• Cord Blood America Details 2010 Business Strategies in Internet Interview
PRNewswire (Fri, Oct 23)
• MoneyTV with Donald Baillargeon, 10/23
Marketwire (Fri, Oct 23)
• Eight Ways to Invest in Cord Blood Industry
at Seeking Alpha (Fri, Oct 23)
• Cord Blood America Details Las Vegas Laboratory Progress in Analyst Interview
PRNewswire (Thu, Oct 15)
• Cord Blood America Announces Debt Reduction Tally: $8.7 Million in 2009; $3.7 Million in Third Quarter
PRNewswire (Wed, Oct 7)
More Headlines for CBAI.OB...
ANALYST
EPS Est (next year) (Dec-69) : N/A
EPS Est (in 2 years) (Dec-69) : N/A
Avg Rec (current)*: N/A
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Cord Blood America, Inc., through its subsidiaries, provides private cord blood stem cell preservation services to families in the United States. It also engages in collecting, processing, and preserving peripheral blood and adipose tissue stem ce...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices